As of 4:02pm ET
| +1.54 / +1.72%|
The 22 analysts offering 12-month price forecasts for Novartis AG have a median target of 92.43, with a high estimate of 106.11 and a low estimate of 68.78. The median estimate represents a +1.23% increase from the last price of 91.30.
The current consensus among 26 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.